|
|
|
Volumn 8, Issue 4, 2006, Pages
|
|
Endocannabinoids - The brain's own marijuana - May be linked to the metabolic syndrome
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 ARACHIDONOYLGLYCEROL;
ANANDAMIDE;
CANNABINOID RECEPTOR;
CANNABIS;
ENDOCANNABINOID;
GLUCOSE;
INSULIN;
LIPID;
RIMONABANT;
PIPERIDINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
BLOOD PRESSURE REGULATION;
BRAIN FUNCTION;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DISEASE ASSOCIATION;
DISEASE MODEL;
DYSLIPIDEMIA;
EDITORIAL;
ENERGY BALANCE;
FEEDING BEHAVIOR;
GLUCOSE HOMEOSTASIS;
HUMAN;
HYPERTENSION;
IMPAIRED GLUCOSE TOLERANCE;
INFLAMMATION;
INSULIN RESISTANCE;
LIPOGENESIS;
METABOLIC SYNDROME X;
NERVE CELL;
NONHUMAN;
OBESITY;
PATHOGENESIS;
POSTSYNAPTIC MEMBRANE;
PRESYNAPTIC NERVE;
PROTEIN LOCALIZATION;
RISK FACTOR;
THROMBOSIS;
TREATMENT OUTCOME;
UNITED STATES;
WEIGHT GAIN;
WEIGHT REDUCTION;
BIOSYNTHESIS;
BRAIN;
DRUG ANTAGONISM;
DRUG EFFECT;
METABOLISM;
BRAIN;
CANNABIS;
ENDOCANNABINOIDS;
HUMANS;
METABOLIC SYNDROME X;
PIPERIDINES;
PYRAZOLES;
|
|
EID: 33750000934
PISSN: 15310132
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (4)
|
